Lunesta
NDC 80725-012, ESZOPICLONE, tablet, coated, from Waylis Therapeutics LLC.
- Product NDC
- 80725-012
- Status
- Listed
- Labeler
- Waylis Therapeutics LLC
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021476
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/80725-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ESZOPICLONE3 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80725-012-30 | 80725001230 | 30 TABLET, COATED in 1 BOTTLE (80725-012-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3821f4b7-a3c8-4920-ba80-18aa96532c09
Use it
Look up 80725-012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80725-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80725-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.